Polarean Imaging plc (AIM:POLX)
1.429
+0.029 (2.07%)
Jul 7, 2025, 10:38 AM GMT+1
Polarean Imaging Revenue
In the year 2024, Polarean Imaging had annual revenue of $3.09M USD with 246.82% growth. Polarean Imaging had revenue of $1.97M in the half year ending December 31, 2024, with 890.35% growth.
Revenue
$3.09M
Revenue Growth
+246.82%
P/S Ratio
6.85
Revenue / Employee
$118.84K
Employees
26
Market Cap
16.90M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.09M | 2.20M | 246.82% |
Dec 31, 2023 | 890.93K | -142.08K | -13.75% |
Dec 31, 2022 | 1.03M | -152.42K | -12.86% |
Dec 31, 2021 | 1.19M | 128.66K | 12.17% |
Dec 31, 2020 | 1.06M | -1.24M | -54.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Polarean Imaging News
- 7 weeks ago - AIM Market Roundup: H&T, Polarean Imaging, Corcel - The Armchair Trader
- 1 year ago - Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives - GlobeNewsWire
- 2 years ago - FDA Approves Polarean's XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation - GlobeNewsWire